JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Differences in Keloid and Hypertrophic Scar Treatment Patterns by Race

Published online August 21, 2026

Dear Editor, Keloids are a dermatologic condition with high recurrence rates and variable treatment success. Racial disparities can play a crucia...

read more
Current Considerations for Laser and Energy-Based Devices in Transgender Patient Care

Published online August 19, 2026

Physical characteristics that can contribute to gender dysphoria in transgender patients, including facial and body hair, hormonal acne...

read more
Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report

Published online August 17, 2026

Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder characterized by violaceous, reticulated skin t...

read more
Review of the Efficacy of Topical 5-Alpha Reductase Inhibitors for the Treatment of Androgenetic Alopecia

Published online August 13, 2026

Androgenetic alopecia (AGA) is a non-scarring alopecia triggered by an inherited follicular sensitivity to dihydrotestosterone (DHT) an...

read more
Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics

Published online July 20, 2026

To the Editor, While biologic medications are frequently used to treat inflammatory skin diseases, patients have experienced paradoxical skin dis...

read more
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum

Published online July 28, 2026

Patients are increasingly turning to social media for disease/treatment advice and support. 1 This has varying benefits 2 but involve...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Improvement of Rosacea With Tirzepatide: A Case Report

Published online July 28, 2026

Tirzepatide is a dual glucagon-like pedtide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) agonist and is primarily used ...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

| Featured Articles, Latest News, Psoriasis | No Comments
Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
Journal of Drugs in Dermatology JDD featuring The State of Sunscreens in the US: Caveat Emptor

The State of Sunscreens in the US: Caveat Emptor

| Featured Articles, Latest News, Photoprotection | No Comments
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor  With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden.

JDD Re:View With Dr. Beer

| Featured Articles, Latest News, Medical Derm, Psoriasis | No Comments
Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…
Journal of Drugs in Dermatology JDD featuring Clinical Characteristics and Time to Onset of JAK-Inhibitor-Associated Acne: A Retrospective Chart Review Study

Clinical Characteristics and Time to Onset of JAK-Inhibitor-Associated Acne: A Retrospective Chart Review Study

| Acne, Featured Articles, Latest News | No Comments
New Data on Acne Linked to Oral JAK Inhibitors: What Dermatology Clinicians Should Know  Have you read this article from the JDD? Acne is emerging as a notable cutaneous adverse…
Journal of Drugs in Dermatology JDD featuring Clinical Characteristics and Time to Onset of JAK-Inhibitor-Associated Acne: A Retrospective Chart Review Study

Use of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals

| Atopic Dermatitis, Featured Articles, Latest News | No Comments
Rapid Itch Relief in Eczema: New JDD Data on Moisturizer and Cream Performance  This is a must-read article from JDD for dermatologists and dermatology healthcare professionals following the day-to-day management…
Journal of Drugs in Dermatology JDD featuring Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis

Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis

| Featured Articles, Latest News, Psoriasis | No Comments
Rapid Clearance Metrics: Evaluating Early Biologic Efficacy in Moderate-to-Severe Plaque Psoriasis  This is a must-read article from the JDD for any clinician managing moderate-to-severe plaque psoriasis in daily practice. As…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Don’t pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind. The world of acne treatment R&D is unfortunately shrinking as payors pick away at the medical necessity of managing the most common inflammatory skin disease. Like Marty McFly fading in that famous family photo, the spotlight on acne is shifting, enough to make Dr. Pimple Punisher Dr. Hilary Baldwin pick up a bottle of Prozac. But all hope is not lost. Join JDD podcast host Dr. Adam Friedman as he and Dr. Baldwin scour the therapeutic landscape and take a sharp left into the over the counter space to review accessible options to manage both the today and tomorrow of Acne Vulgaris, the symbiosis between RX and OTC to address barrier dysfunction, scarring and hyperpigmentation.

State of the Acne Management Union: Stud or Dud?

| Acne, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Don't pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind.  The world of acne treatment R&D is unfortunately shrinking as payors pick away…
Tune In

Follow Us